financetom
Business
financetom
/
Business
/
Monday.com Extends AI Push, Grows Big-Client Base — Market Unimpressed
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Monday.com Extends AI Push, Grows Big-Client Base — Market Unimpressed
Aug 11, 2025 6:35 AM

Monday.com ( MNDY ) stock dropped on Monday after it posted second-quarter results.

The company reported a quarterly revenue growth of 27% year-on-year (Y/Y) to $299.01 million, beating the analyst consensus estimate of $293.54 million. 

The project management software company’s adjusted EPS of $1.09 beat the analyst consensus estimate of 86 cents.

Also Read: Monday.com’s Strong Q1, Big Customer Growth, High Margins Drive Bullish Wall Street Outlook

Monday.com ( MNDY ) makes money from selling subscriptions to customers to access its cloud-based Work OS platform. 

The net dollar retention rate was 111% and 115% for customers with more than ten users.

The number of paid customers with over $50,000 in annual recurring revenue (ARR) rose 36% Y/Y to 3,702. The adjusted operating margin decreased 100 bps to 15%.

In the quarter, Monday.com ( MNDY ) generated an operating cash flow of $66.84 million compared to $55.79 million a year ago.

It generated $64.09 million in adjusted free cash flow, compared to $50.82 million a year ago, and ended the quarter with $1.65 billion in cash and equivalents.

Monday.com ( MNDY ) co-founders and co-CEOs Roy Mann and Eran Zinman reported revenue growth accelerating and enterprise demand for the company’s broad product suite expanding rapidly. They highlighted how the company’s AI innovation is delivering measurable value. They said that by enhancing platform flexibility, the new AI capabilities address core challenges across all product areas and help users prioritize their most critical strategic initiatives.

Outlook

Monday.com ( MNDY ) expects fiscal third-quarter 2025 revenue of $311.00 million-$313.00 million against the analyst consensus estimate of $312.95 million and an adjusted operating margin of 11%-12%.

Monday.com ( MNDY ) expects 2025 revenue of $1.224 billion-$1.229 billion (prior $1.220 billion-$1.226 billion), against the analyst consensus estimate of $1.220 billion, and an adjusted operating margin of approximately 13%.

The stock gained over 5% year-to-date.

Price Action: Monday.com ( MNDY ) stock is trading lower by 18.7% to $201.72 premarket at last check Monday.

Read Next:

Warner Bros. Stock Slides After Analysts Flag Second-Half Challenges

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Street Color: Pink Floyd Inks Deal to Sell Music Rights to Sony for $400 Million, Financial Times Reports
--Street Color: Pink Floyd Inks Deal to Sell Music Rights to Sony for $400 Million, Financial Times Reports
Oct 2, 2024
01:34 PM EDT, 10/01/2024 (MT Newswires) -- Price: 96.34, Change: -0.23, Percent Change: -0.24 ...
Peloton beats shareholder lawsuit over post-pandemic financial forecasts
Peloton beats shareholder lawsuit over post-pandemic financial forecasts
Oct 2, 2024
NEW YORK (Reuters) - Peloton Interactive ( PTON ) won dismissal of a lawsuit claiming it defrauded shareholders by concealing how demand for its home exercise equipment, which surged after the COVID-19 pandemic began, was declining as vaccines became available and gyms began reopening. In a Monday night decision, U.S. District Judge Andrew Carter in Manhattan said several optimistic Peloton...
Teva Launches Generic Version Of Sandostatin In The US
Teva Launches Generic Version Of Sandostatin In The US
Oct 2, 2024
Shares of Teva Pharmaceutical Industries ( TEVA ) on Tuesday the launch of the first and only generic version of Sandostatin LAR Depot (octreotide acetate for injectable suspension) in the U.S. Teva's new generic drug is used to treat acromegaly—a condition characterized by excessive growth hormone—and severe diarrhea in patients with carcinoid syndrome, a complication of certain cancers. With annual...
Tesla Remixes The Tune: LiveOne Shares Dip After Partnership Changes And Slashed Revenue Guidance
Tesla Remixes The Tune: LiveOne Shares Dip After Partnership Changes And Slashed Revenue Guidance
Oct 2, 2024
LiveOne, Inc. ( LVO ) shares are trading lower on Tuesday following its amended partnership with Tesla, Inc. ( TSLA ) . LiveOne ( LVO ) renewed its partnership with the EV behemoth through May 2026. Effective today, Tesla replaced its streaming button with LiveOne’s in perpetuity. The company also announced the launch of its LiveOne ( LVO ) 2.0, for...
Copyright 2023-2026 - www.financetom.com All Rights Reserved